THE Senate hearing on the controversy involving an anti-dengue vaccine resumed today, Wednesday, with the inquiry to focus on the alleged negligence of former health officials in implementing the government’s immunization program.

Health officials are accused of allegedly rushing the purchase of the Dengvaxia vaccine without proper study on its possible side effects on its recipients, mostly children.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details